| Literature DB >> 24855941 |
Mohamed Lamkanfi1, Vishva M Dixit2.
Abstract
Recent studies have offered a glimpse into the sophisticated mechanisms by which inflammasomes respond to danger and promote secretion of interleukin (IL)-1β and IL-18. Activation of caspases 1 and 11 in canonical and noncanonical inflammasomes, respectively, also protects against infection by triggering pyroptosis, a proinflammatory and lytic mode of cell death. The therapeutic potential of inhibiting these proinflammatory caspases in infectious and autoimmune diseases is raised by the successful deployment of anti-IL-1 therapies to control autoinflammatory diseases associated with aberrant inflammasome signaling. This Review summarizes recent insights into inflammasome biology and discusses the questions that remain in the field.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24855941 DOI: 10.1016/j.cell.2014.04.007
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582